Details for New Drug Application (NDA): 213232
✉ Email this page to a colleague
The generic ingredient in VERAPAMIL HYDROCHLORIDE is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
Summary for 213232
Tradename: | VERAPAMIL HYDROCHLORIDE |
Applicant: | Caplin |
Ingredient: | verapamil hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 213232
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 213232 | ANDA | Baxter Healthcare Corporation | 43066-031 | 43066-031-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (43066-031-25) / 2 mL in 1 VIAL, SINGLE-DOSE (43066-031-01) |
VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 213232 | ANDA | Baxter Healthcare Corporation | 43066-035 | 43066-035-05 | 5 VIAL, SINGLE-DOSE in 1 CARTON (43066-035-05) / 4 mL in 1 VIAL, SINGLE-DOSE (43066-035-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5MG/2ML (2.5MG/ML) | ||||
Approval Date: | Mar 25, 2020 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/4ML (2.5MG/ML) | ||||
Approval Date: | Mar 25, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription